Wendy S. Johnson - Net Worth and Insider Trading
Wendy S. Johnson Net Worth
The estimated net worth of Wendy S. Johnson is at least $2,039 dollars as of 2024-06-08. Wendy S. Johnson is the Director of Exagen Inc and owns about 1,000 shares of Exagen Inc (XGN) stock worth over $2,020. Wendy S. Johnson is the Interim Chief Operating Office of Armata Pharmaceuticals Inc and owns about 7 shares of Armata Pharmaceuticals Inc (ARMP) stock worth over $19. Wendy S. Johnson is also the Chief Development Officer of Reneo Pharmaceuticals Inc and owns about 0 shares of Reneo Pharmaceuticals Inc (RPHM) stock worth over $0. Details can be seen in Wendy S. Johnson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wendy S. Johnson has not made any transactions after 2021-09-03 and currently still holds the listed stock(s).
Transaction Summary of Wendy S. Johnson
Wendy S. Johnson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wendy S. Johnson owns 3 companies in total, including Exagen Inc (XGN) , Armata Pharmaceuticals Inc (ARMP) , and Reneo Pharmaceuticals Inc (RPHM) .
Click here to see the complete history of Wendy S. Johnson’s form 4 insider trades.
Insider Ownership Summary of Wendy S. Johnson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XGN | Exagen Inc | 2021-09-03 | director |
| ARMP | Armata Pharmaceuticals Inc | 2015-10-05 | director & See Remarks |
| RPHM | Reneo Pharmaceuticals Inc | 2021-07-14 | Chief Development Officer |
Wendy S. Johnson Latest Holdings Summary
Wendy S. Johnson currently owns a total of 3 stocks. Among these stocks, Wendy S. Johnson owns 1,000 shares of Exagen Inc (XGN) as of September 3, 2021, with a value of $2,020 and a weighting of 99.07%. Wendy S. Johnson owns 7 shares of Armata Pharmaceuticals Inc (ARMP) as of October 5, 2015, with a value of $19 and a weighting of 0.93%. Wendy S. Johnson also owns 0 shares of Reneo Pharmaceuticals Inc (RPHM) as of July 14, 2021, with a value of $0 and a weighting of 0%.
Latest Holdings of Wendy S. Johnson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XGN | Exagen Inc | 2021-09-03 | 1,000 | 2.02 | 2,020 |
| ARMP | Armata Pharmaceuticals Inc | 2015-10-05 | 7 | 2.72 | 19 |
| RPHM | Reneo Pharmaceuticals Inc | 2021-07-14 | 0 | 1.67 | 0 |
Holding Weightings of Wendy S. Johnson
Wendy S. Johnson Form 4 Trading Tracker
According to the SEC Form 4 filings, Wendy S. Johnson has made a total of 1 transactions in Exagen Inc (XGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Exagen Inc is the acquisition of 1,000 shares on September 3, 2021, which cost Wendy S. Johnson around $14,020.
According to the SEC Form 4 filings, Wendy S. Johnson has made a total of 0 transactions in Armata Pharmaceuticals Inc (ARMP) over the past 5 years. The most-recent trade in Armata Pharmaceuticals Inc is the acquisition of 7 shares on October 5, 2015, which cost Wendy S. Johnson around $4,430.
According to the SEC Form 4 filings, Wendy S. Johnson has made a total of 1 transactions in Reneo Pharmaceuticals Inc (RPHM) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Reneo Pharmaceuticals Inc is the sale of 111,736 shares on July 14, 2021, which brought Wendy S. Johnson around $949,756.
Insider Trading History of Wendy S. Johnson
- 1
Wendy S. Johnson Trading Performance
GuruFocus tracks the stock performance after each of Wendy S. Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wendy S. Johnson is -20.59%. GuruFocus also compares Wendy S. Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wendy S. Johnson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wendy S. Johnson's insider trading performs compared to the benchmark.
Performance of Wendy S. Johnson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.29 | | | | | |
| Relative Return to S&P 500(%) | 14.41 | | | | | |
Wendy S. Johnson Ownership Network
Wendy S. Johnson Owned Company Details
What does Exagen Inc do?
Who are the key executives at Exagen Inc?
Wendy S. Johnson is the director of Exagen Inc. Other key executives at Exagen Inc include director & President and CEO John Aballi , Chief Financial Officer Kamal Adawi , and 10 percent owner Tullis Growth Fund Ii, L.p. .
Exagen Inc (XGN) Insider Trades Summary
Over the past 18 months, Wendy S. Johnson made no insider transaction in Exagen Inc (XGN). Other recent insider transactions involving Exagen Inc (XGN) include a net sale of 25,343 shares made by Kamal Adawi , a net purchase of 6,582 shares made by John Aballi , and a net sale of 5,821 shares made by Mark Hazeltine .
In summary, during the past 3 months, insiders sold 0 shares of Exagen Inc (XGN) in total and bought 40,401 shares, with a net purchase of 40,401 shares. During the past 18 months, 64,983 shares of Exagen Inc (XGN) were sold and 40,568 shares were bought by its insiders, resulting in a net sale of 24,415 shares.
Exagen Inc (XGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Exagen Inc Insider Transactions
Wendy S. Johnson Mailing Address
Above is the net worth, insider trading, and ownership report for Wendy S. Johnson. You might contact Wendy S. Johnson via mailing address: 800 E. Leigh Street, Suite 209, Richmond Va 21219.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
